Yoav Nissan-Cohen

Dr Nissan-Cohen's career covers over 40 years of scientific research, technology development and executive management in the tech industry. He started his career as a research scientist in GE's R&D centre in New York where he studied the use of silicon dioxide in semiconductor memory devices. He then established Tower 17 He was a founding member of Investec Bank Australia and worked at William Buck Chartered Accountants, ANZ Corporate Finance (London) and ANZ Private Bank (Australia). Ashley is a founding partner of OurCrowd, one of the global technology venture investing platforms. He is also a founding partner and shareholder of technology companies spanning the sectors of nanotech, medtech, fintech and renewable energy. Last Three Years Directorships of Listed Companies None Semiconductor, a Nasdaq listed, global specialty semiconductor foundry leader with a market cap of US$5 billion, where he served as CEO for nine years. Dr Nissan Cohen also played a role in establishing a non volatile technology startup, Saifun Semiconductor, which was subsequently sold to Spansion. After two years in the venture capital industry, he returned to his entrepreneurial origins taking up Chairman and CEO positions in Amimon until its acquisition by Videndum plc. In addition to his role as a director in Weebit, he is currently leading Teracyte, which develops a throughput, rich data platform to enable predictive AI applications in the biotechnology and pharma industries.